As Complete Genomics sought to boost its resources with a partnership with a Chinese biotechnology concern, a rival company has made a competitive bid. Illumina said last week that the company made a competing bid for Complete Genomics Inc. at a 5% premium over what Chinese firm BGI-Shenzhen has offered shareholders. Previous to the offer, Complete Genomics agreed to be acquired.
Complete Genomics said that Illumina's bid wasn't in the best interests of the stockholders, because a potential deal would likely not achieve antitrust clearance. Complete Genomics and Illumina compete for whole human genome sequencing as an outsourced service.
The competition is indicative of the attention that companies are giving the DNA Sequencing market, as expected clinical application drive development of new systems and applications. Kalorama Information's report on The DNA Sequencing Equipment and Services Market provides complete forecasts for systems and consumables used in DNA Sequencing. It also contains company profiles, grant trends and other information. The report can be found at: http://www.kaloramainformation.com/DNA-Sequencing-Equipment-7118427/